Literature DB >> 24446561

Status quo of hybrid coronary revascularization for multi-vessel coronary artery disease.

Ralf E Harskamp, Zhe Zheng, John H Alexander, Judson B Williams, Ying Xian, Michael E Halkos, J Matthew Brennan, Robbert J de Winter, Peter K Smith, Renato D Lopes.   

Abstract

Hybrid coronary revascularization (HCR) combines bypass grafting of the left anterior descending (LAD) coronary artery with percutaneous coronary intervention (PCI) of non-LAD vessels. HCR has been performed as an alternative to CABG or multi-vessel PCI in thousands of patients since the late 1990s. In this review article, we provide an overview on patient selection, procedural sequence and timing, use of surgical techniques and anti-platelet agents. Additionally, patient recovery, satisfaction, costs and clinical outcomes of individual studies after HCR are evaluated. Future directions are also discussed, including the need for adequately powered randomized trials.

Entities:  

Mesh：

Year:  2013        PMID： 24446561      PMCID： PMC4339110          DOI： 10.1016/j.athoracsur.2013.07.093

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN： 0003-4975            Impact factor:   4.330


  65 in total

1.  Hybrid coronary revascularization versus off-pump coronary artery bypass grafting for the treatment of multivessel coronary artery disease.

Authors:  Michael E Halkos; Thomas A Vassiliades; John S Douglas; Douglas C Morris; S Tanveer Rab; Henry A Liberman; Habib Samady; Patrick D Kilgo; Robert A Guyton; John D Puskas
Journal:  Ann Thorac Surg       Date:  2011-09-21       Impact factor: 4.330

2.  Simultaneous integrated coronary artery revascularization with long-term angiographic follow-up.

Authors:  Bob Kiaii; R Scott McClure; Peter Stewart; Reiza Rayman; Stuart A Swinamer; Yoshihiro Suematsu; Stephanie Fox; Jennifer Higgins; Caroline Albion; William J Kostuk; David Almond; Kumar Sridhar; Patrick Teefy; George Jablonsky; Pantelis Diamantouros; Wojciech B Dobkowski; Philip Jones; Daniel Bainbridge; Ivan Iglesias; John Murkin; Davy Cheng; Richard J Novick
Journal:  J Thorac Cardiovasc Surg       Date:  2008-09       Impact factor: 5.209

3.  Percutaneous coronary intervention in native arteries versus bypass grafts in prior coronary artery bypass grafting patients: a report from the National Cardiovascular Data Registry.

Authors:  Emmanouil S Brilakis; Sunil V Rao; Subhash Banerjee; Steven Goldman; Kendrick A Shunk; David R Holmes; Emily Honeycutt; Matthew T Roe
Journal:  JACC Cardiovasc Interv       Date:  2011-08       Impact factor: 11.195

4.  Developing a new hybrid revascularization program: a road map for hospital managers and physician leaders.

Authors:  Kishore J Harjai; Sanjay Samy; Barbara Pennypacker; Bonnie Onofre; Pamela Stanfield; Lynne Yaeger; Dwight Stapleton; Barry C Esrig
Journal:  J Interv Cardiol       Date:  2012-08-02       Impact factor: 2.279

5.  Myocardial "hybrid" revascularisation with minimally invasive direct coronary artery bypass grafting combined with coronary angioplasty: preliminary results of a multicentre study.

Authors:  T Wittwer; J Cremer; P Boonstra; J Grandjean; M Mariani; A Mügge; H Drexler; P den Heijer; E R Leitner; A Hepp; M Wehr; A Haverich
Journal:  Heart       Date:  2000-01       Impact factor: 5.994

6.  Factors contributing to the lower mortality with ticagrelor compared with clopidogrel in patients undergoing coronary artery bypass surgery.

Authors:  Christoph Varenhorst; Ulrica Alström; Benjamin M Scirica; Charles W Hogue; Nils Åsenblad; Robert F Storey; Ph Gabriel Steg; Jay Horrow; Kenneth W Mahaffey; Richard C Becker; Stefan James; Christopher P Cannon; Gunnar Brandrup-Wognsen; Lars Wallentin; Claes Held
Journal:  J Am Coll Cardiol       Date:  2012-09-26       Impact factor: 24.094

7.  Clinical outcome after surgical or percutaneous revascularization in coronary bypass graft failure.

Authors:  Ralf E Harskamp; Marcel A Beijk; Peter Damman; Wichert J Kuijt; Pier Woudstra; Maik J Grundeken; Jaap J Kloek; Jan G Tijssen; Bas A de Mol; Robbert J de Winter
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2013-06       Impact factor: 2.160

8.  Alternative approach to multivessel coronary disease with integrated coronary revascularization.

Authors:  M Zenati; H A Cohen; B P Griffith
Journal:  J Thorac Cardiovasc Surg       Date:  1999-03       Impact factor: 5.209

9.  Percutaneous treatment of multivessel coronary disease in the drug eluting stent era: comparison of bare-metal stents, drug-eluting stents and a mixed approach in a large multicentre registry.

Authors:  Elisabetta Varani; Francesco Saia; Marco Balducelli; Paolo Guastaroba; Cinzia Marrozzini; Fabio Tarantino; Francesco Passerini; Pietro Sangiorgio; Gianfranco Percoco; Roberto Grilli; Antonio Marzocchi; Aleardo Maresta
Journal:  EuroIntervention       Date:  2007-02       Impact factor: 6.534

10.  Simultaneous hybrid coronary revascularization using totally endoscopic left internal mammary artery bypass grafting and placement of rapamycin eluting stents in the same interventional session. The COMBINATION pilot study.

Authors:  Johannes Bonatti; Thomas Schachner; Nikolaos Bonaros; Patrycja Jonetzko; Armin Ohlinger; Elisabeth Ruetzler; Christian Kolbitsch; Gudrun Feuchtner; Guenther Laufer; Otmar Pachinger; Guy Friedrich
Journal:  Cardiology       Date:  2007-10-31       Impact factor: 1.869
View more
  5 in total

Review 1.  Meta-analysis of minimally invasive coronary artery bypass versus drug-eluting stents for isolated left anterior descending coronary artery disease.

Authors:  Ralf E Harskamp; Judson B Williams; Michael E Halkos; Renato D Lopes; Jan G P Tijssen; T Bruce Ferguson; Robbert J de Winter
Journal:  J Thorac Cardiovasc Surg       Date:  2014-03-20       Impact factor: 5.209

2.  Hybrid coronary revascularization: present indications and future perspective.

Authors:  Konstantinos Voudris; Dimitrios V Avgerinos; Dmitriy Feldman; Konstantinos Charitakis
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-03

3.  Minimally invasive surgical techniques in the era of hybrid coronary revascularization: additional benefits for the elderly patients?

Authors:  Antonio Nenna; Mario Lusini; Salvatore Matteo Greco; Elvio Covino; Massimo Chello
Journal:  J Geriatr Cardiol       Date:  2016-10       Impact factor: 3.327

4.  Mid-term follow-up outcomes of 2-staged hybrid coronary revascularization compared with off-pump coronary artery bypass for patients with multivessel coronary artery disease.

Authors:  Song Wu; Yunpeng Ling; Yuanhao Fu; Lufeng Zhang; Hang Yang; Lijun Guo; Wei Gao; Feng Wan
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2017-03-27       Impact factor: 1.195

Review 5.  Clinical Outcomes of Revascularization Strategies for Patients With MVD/LMCA Disease: A Systematic Review and Network Meta-Analysis.

Authors:  Meng-Kan Fan; Ya-Min Su; Xing-Xing Cai; Zhou-Shan Gu; Hai-Hua Geng; Hai-Yan Pan; Jian-Hua Zhu; Min Pan
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.